The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback